Skip to main content
Top
Published in: BMC Infectious Diseases 1/2020

Open Access 01-12-2020 | Community-Acquired Pneumonia | Research article

The clinical significance of IL-6 s and IL-27 s in Bronchoalveolar lavage fluids from children with mycoplasma pneumoniae pneumonia

Authors: Jie Zhao, Yuyun Li, Wen Zhang

Published in: BMC Infectious Diseases | Issue 1/2020

Login to get access

Abstract

Background

IL-6 was associated with the severity of mycoplasma pneumoniae pneumonia (MPP). But the relationship between IL-27 and MPP was unknown.

Methods

Ninety-eight patients with MPP < 14 years old were enrolled in this study and divided into groups by severity (mild cases and severe cases), infection types (MP single infection group and MP mixed infection group) and DNA loads (low MP DNA loads group and high MP DNA loads group), respectively. Fifteen children with foreign bodies in bronchus were also enrolled as control. IL-6 s and IL-27 s in bronchoalveolar lavage fluids (BALFs) from these children were measured by ELISA.

Results

There were significant differences in IL-6 s of BALFs from patients between mild cases and severe cases, MP single infection group and MP mixed infection group, and low MP DNA loads group and high MP DNA loads group, respectively (P < 0.05). Compared with IL-6 s of BALFs from control, IL-6 s in BALFs from the 6 patient groups were significantly higher (P < 0.05). IL-27 s in BALFs from MP mixed infection group were significantly lower than those from MP single infection group and control (P < 0.05) respectively.

Conclusion

IL-6 was firmly associated with MPP and had potential application in clinical practice while IL-27 was not related to MP infection.
Literature
1.
go back to reference Sondergaard MJ, Friis MB, Hansen DS, Jorgensen IM. Clinical manifestations in infants and children with mycoplasma pneumoniae infection. PLoS One. 2018;13:e0195288.CrossRef Sondergaard MJ, Friis MB, Hansen DS, Jorgensen IM. Clinical manifestations in infants and children with mycoplasma pneumoniae infection. PLoS One. 2018;13:e0195288.CrossRef
2.
go back to reference Cheong KN, Chiu SS, Chan BW, To KK, Chan EL, Ho PL. Severe macrolide-resistant mycoplasma pneumoniae pneumonia associated with macrolide failure. J Microbiol Immunol Infect. 2016;49:127–30.CrossRef Cheong KN, Chiu SS, Chan BW, To KK, Chan EL, Ho PL. Severe macrolide-resistant mycoplasma pneumoniae pneumonia associated with macrolide failure. J Microbiol Immunol Infect. 2016;49:127–30.CrossRef
3.
go back to reference Chaudhry R, Ghosh A, Chandolia A. Pathogenesis of mycoplasma pneumoniae: an update. Indian J Med Microbiol. 2016;34:7–16.CrossRef Chaudhry R, Ghosh A, Chandolia A. Pathogenesis of mycoplasma pneumoniae: an update. Indian J Med Microbiol. 2016;34:7–16.CrossRef
4.
go back to reference Inamura N, Miyashita N, Hasegawa S, Kato A, Fukuda Y, Saitoh A, et al. Management of refractory mycoplasma pneumoniae pneumonia: utility of measuring serum lactate dehydrogenase level. J of Infect Chemother. 2014;20:270–3.CrossRef Inamura N, Miyashita N, Hasegawa S, Kato A, Fukuda Y, Saitoh A, et al. Management of refractory mycoplasma pneumoniae pneumonia: utility of measuring serum lactate dehydrogenase level. J of Infect Chemother. 2014;20:270–3.CrossRef
5.
go back to reference Saraya T. Mycoplasma pneumoniae infection: basics. J Gen Fam Med. 2017;18:118–25.CrossRef Saraya T. Mycoplasma pneumoniae infection: basics. J Gen Fam Med. 2017;18:118–25.CrossRef
6.
go back to reference Akdis M, Aab A, Altunbulakli C, Azkur K, Costa RA, Crameri R, et al. Interleukins (from IL-1 to IL-38), interferons, transforming growth factor beta, and TNF-alpha: Receptors, functions, and roles in diseases. J Allergy Clin Immunol. 2016;138:984–1010.CrossRef Akdis M, Aab A, Altunbulakli C, Azkur K, Costa RA, Crameri R, et al. Interleukins (from IL-1 to IL-38), interferons, transforming growth factor beta, and TNF-alpha: Receptors, functions, and roles in diseases. J Allergy Clin Immunol. 2016;138:984–1010.CrossRef
7.
go back to reference He J, Liu M, Ye Z, Tan T, Liu X, You X, et al. Insights into the pathogenesis of mycoplasma pneumoniae. Mol Med Rep. 2016;14:4030–6.CrossRef He J, Liu M, Ye Z, Tan T, Liu X, You X, et al. Insights into the pathogenesis of mycoplasma pneumoniae. Mol Med Rep. 2016;14:4030–6.CrossRef
8.
go back to reference Hsieh CC, Tang RB, Tsai CH, Chen W. Serum interleukin-6 and tumor necrosis factor-alpha concentrations in children with mycoplasma pneumonia. J Microbiol Immunol Infect. 2001;34:109–12.PubMed Hsieh CC, Tang RB, Tsai CH, Chen W. Serum interleukin-6 and tumor necrosis factor-alpha concentrations in children with mycoplasma pneumonia. J Microbiol Immunol Infect. 2001;34:109–12.PubMed
9.
go back to reference Guzzo C, Che Mat NF, Gee K. Interleukin-27 induces a STAT1/3- and NF-kappaB-dependent proinflammatory cytokine profile in human monocytes. J Biol Chem. 2010;285:24404–11.CrossRef Guzzo C, Che Mat NF, Gee K. Interleukin-27 induces a STAT1/3- and NF-kappaB-dependent proinflammatory cytokine profile in human monocytes. J Biol Chem. 2010;285:24404–11.CrossRef
10.
go back to reference Stumhofer JS, Tait ED, Quinn WJ 3rd, Hosken N, Spudy B, Goenka R, et al. A role for IL-27p28 as an antagonist of gp130-mediated signaling. Nat Immunol. 2010;11:1119–26.CrossRef Stumhofer JS, Tait ED, Quinn WJ 3rd, Hosken N, Spudy B, Goenka R, et al. A role for IL-27p28 as an antagonist of gp130-mediated signaling. Nat Immunol. 2010;11:1119–26.CrossRef
11.
go back to reference Pflanz S, Timans JC, Cheung J, Rosales R, Kanzler H, Gilbert J, et al. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells. Immunity. 2002;16:779–90.CrossRef Pflanz S, Timans JC, Cheung J, Rosales R, Kanzler H, Gilbert J, et al. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells. Immunity. 2002;16:779–90.CrossRef
12.
go back to reference Jiang ZF, Shen KL, Shen Y, Ni X, Yu G, Ma L, et al. Zhu Futang Practice of Pediatrics 8th Edition. People’s Medical Publishing House of China; 2015. p. 1253–82. Jiang ZF, Shen KL, Shen Y, Ni X, Yu G, Ma L, et al. Zhu Futang Practice of Pediatrics 8th Edition. People’s Medical Publishing House of China; 2015. p. 1253–82.
13.
go back to reference Cho YJ, Han MS, Kim WS, Choi EH, Choi YH, Yun KW, et al. Correlation between chest radiographic findings and clinical features in hospitalized children with mycoplasma pneumoniae pneumonia. PLoS One. 2019;14:e0219463.CrossRef Cho YJ, Han MS, Kim WS, Choi EH, Choi YH, Yun KW, et al. Correlation between chest radiographic findings and clinical features in hospitalized children with mycoplasma pneumoniae pneumonia. PLoS One. 2019;14:e0219463.CrossRef
14.
go back to reference Wang K, Gao M, Meng F, Li D, Lu R, Wang Y, et al. Transcriptome analysis of bronckoalveolar lavage fluid from children with severe mycoplasma pneumoniae pneumonia reveals novel gene expression and immunodeficiency. Hum Genomics. 2017;11(1):4–4.CrossRef Wang K, Gao M, Meng F, Li D, Lu R, Wang Y, et al. Transcriptome analysis of bronckoalveolar lavage fluid from children with severe mycoplasma pneumoniae pneumonia reveals novel gene expression and immunodeficiency. Hum Genomics. 2017;11(1):4–4.CrossRef
15.
go back to reference Tashiro M, Fushimi K, Kawano K, Takazono T, Saijo T, Yamamoto K, et al. Adjunctive corticosteroid therapy for inpatients with Mycoplasma pneumoniae pneumonia. BMC Pulm Med. 2017;17:219.CrossRef Tashiro M, Fushimi K, Kawano K, Takazono T, Saijo T, Yamamoto K, et al. Adjunctive corticosteroid therapy for inpatients with Mycoplasma pneumoniae pneumonia. BMC Pulm Med. 2017;17:219.CrossRef
16.
go back to reference Qiu L, Wang L, Tan L, Li M, Wu C, Li L, et al. Molecular characterization of genomic DNA in Mycoplasma pneumoniae strains isolated from serious mycoplasma pneumonia cases in 2016, Yunnan, China. Infect Genet Evol. 2018;58:125–34.CrossRef Qiu L, Wang L, Tan L, Li M, Wu C, Li L, et al. Molecular characterization of genomic DNA in Mycoplasma pneumoniae strains isolated from serious mycoplasma pneumonia cases in 2016, Yunnan, China. Infect Genet Evol. 2018;58:125–34.CrossRef
17.
go back to reference Zhao J, Zhang W, Shen L, Yang X, Liu Y, Gai Z. Association of the ACE, GSTM1, IL-6, NOS3 and CYP1A1 polymorphisms with susceptibility of mycoplasma pneumoniae pneumonia in Chinese Children. Medicine (Baltimore). 2017;96:e6642.CrossRef Zhao J, Zhang W, Shen L, Yang X, Liu Y, Gai Z. Association of the ACE, GSTM1, IL-6, NOS3 and CYP1A1 polymorphisms with susceptibility of mycoplasma pneumoniae pneumonia in Chinese Children. Medicine (Baltimore). 2017;96:e6642.CrossRef
18.
go back to reference Dienz O, Rud JG, Eaton SM, Lanthier PA, Burg E, Drew A, et al. Essential role of IL-6 in protection against H1N1 influenza virus by promoting neutrophil survival in the lung. Mucosal Immunol. 2012;5:258–66.CrossRef Dienz O, Rud JG, Eaton SM, Lanthier PA, Burg E, Drew A, et al. Essential role of IL-6 in protection against H1N1 influenza virus by promoting neutrophil survival in the lung. Mucosal Immunol. 2012;5:258–66.CrossRef
19.
go back to reference Zhang Y, Mei S, Zhou Y, Huang M, Dong G, Chen Z. Cytokines as the good predictors of refractory Mycoplasma pneumoniae pneumonia in school-aged children. Sci Rep. 2016;6:37037.CrossRef Zhang Y, Mei S, Zhou Y, Huang M, Dong G, Chen Z. Cytokines as the good predictors of refractory Mycoplasma pneumoniae pneumonia in school-aged children. Sci Rep. 2016;6:37037.CrossRef
20.
go back to reference Zhao JL, Wang X, Wang YS. Relationships between Th1/Th2 cytokine profiles and chest radiographic manifestations in childhood Mycoplasma pneumoniae pneumonia. Ther Clin Risk Manag. 2016;12:1683–92.CrossRef Zhao JL, Wang X, Wang YS. Relationships between Th1/Th2 cytokine profiles and chest radiographic manifestations in childhood Mycoplasma pneumoniae pneumonia. Ther Clin Risk Manag. 2016;12:1683–92.CrossRef
21.
go back to reference Guo L, Liu F, Lu MP, Zheng Q, Chen ZM. Increased T cell activation in BALF from children with mycoplasma pneumoniae pneumonia. Pediatr Pulmonol. 2015;50:814–9.CrossRef Guo L, Liu F, Lu MP, Zheng Q, Chen ZM. Increased T cell activation in BALF from children with mycoplasma pneumoniae pneumonia. Pediatr Pulmonol. 2015;50:814–9.CrossRef
22.
go back to reference Villarino AV, Larkin J 3rd, Saris CJ, Caton AJ, Lucas S, Wong T, et al. Positive and negative regulation of the IL-27 receptor during lymphoid cell activation. J Immunol. 2005;174:7684–91.CrossRef Villarino AV, Larkin J 3rd, Saris CJ, Caton AJ, Lucas S, Wong T, et al. Positive and negative regulation of the IL-27 receptor during lymphoid cell activation. J Immunol. 2005;174:7684–91.CrossRef
23.
go back to reference Neurath MF. New therapies for sepsis: focus on the interleukin (IL) 12 family member IL 27. Ann Rheum Dis. 2007;(Suppl 3):iii29–31. Neurath MF. New therapies for sepsis: focus on the interleukin (IL) 12 family member IL 27. Ann Rheum Dis. 2007;(Suppl 3):iii29–31.
Metadata
Title
The clinical significance of IL-6 s and IL-27 s in Bronchoalveolar lavage fluids from children with mycoplasma pneumoniae pneumonia
Authors
Jie Zhao
Yuyun Li
Wen Zhang
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2020
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-020-05017-3

Other articles of this Issue 1/2020

BMC Infectious Diseases 1/2020 Go to the issue